Drug Standards
- (2)
- (4)
- (1)
- (3)
- (3)
- (665)
- (3)
- (27)
- (1)
- (6)
- (27)
- (61)
- (24)
- (1)
- (2)
- (35)
- (367)
- (45)
- (1)
- (2)
- (1)
- (5)
- (5)
- (4)
- (2)
- (7)
- (1)
- (5)
- (4)
- (3)
- (3)
- (1)
- (3)
- (2)
- (2)
- (1)
- (3)
- (4)
- (2)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (4)
- (1)
- (1)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (5)
- (1)
- (2)
- (4)
- (1)
- (3)
- (5)
- (3)
- (1)
- (2)
- (1)
- (3)
- (1)
- (1)
- (3)
- (4)
- (2)
- (2)
- (1)
- (4)
- (4)
- (5)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (4)
- (3)
- (1)
- (2)
- (1)
- (2)
- (1)
- (5)
- (2)
- (2)
- (1)
- (5)
- (7)
- (3)
- (1)
- (1)
- (1)
- (4)
- (3)
- (1)
- (4)
- (1)
- (8)
- (2)
- (1)
- (5)
- (13)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (4)
- (1)
- (5)
- (1)
- (1)
- (2)
- (1)
- (6)
- (2)
- (1)
- (2)
- (1)
- (3)
- (2)
- (1)
- (3)
- (3)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (1)
- (2)
- (4)
- (3)
- (1)
- (1)
- (5)
- (3)
- (2)
- (5)
- (1)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (4)
- (4)
- (1)
- (2)
- (2)
- (1)
- (2)
- (4)
- (5)
- (2)
- (1)
- (3)
- (2)
- (2)
- (11)
- (2)
- (2)
- (2)
- (5)
- (5)
- (4)
- (2)
- (4)
- (2)
- (1)
- (2)
- (5)
- (2)
- (1)
- (2)
- (3)
- (2)
- (2)
- (5)
- (3)
- (2)
- (2)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (2)
- (3)
- (2)
- (2)
- (3)
- (2)
- (1)
- (1)
- (5)
- (1)
- (2)
- (5)
- (5)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (7)
- (2)
- (2)
- (1)
- (3)
- (1)
- (3)
- (2)
- (5)
- (2)
- (2)
- (2)
- (2)
- (5)
- (2)
- (1)
- (6)
- (3)
- (2)
- (1)
- (5)
- (5)
- (2)
- (2)
- (1)
- (6)
- (1)
- (1)
- (1)
- (5)
- (1)
- (2)
- (4)
- (1)
- (3)
- (1)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (1)
- (1)
- (5)
- (2)
- (2)
- (1)
- (1)
- (2)
- (8)
- (4)
- (14)
- (7)
- (8)
- (1)
- (3)
- (1)
- (6)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (20)
- (4)
- (5)
- (1)
- (3)
- (2)
- (1)
- (7)
- (8)
- (7)
- (1)
- (2)
- (1)
- (3)
- (5)
- (5)
- (1)
- (3)
- (1)
- (3)
- (6)
- (3)
- (3)
- (1)
- (2)
- (26)
- (54)
- (5)
- (6)
- (4)
- (6)
- (6)
- (16)
- (1)
- (129)
- (3)
- (1)
- (2)
- (5)
- (4)
- (13)
- (38)
- (3)
- (13)
- (12)
- (7)
- (1)
- (6)
- (6)
- (6)
- (1)
- (1)
- (1)
- (1)
- (1)
- (12)
- (38)
- (5)
- (1)
- (2)
- (1)
- (1)
- (12)
- (2)
- (15)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (6)
- (15)
- (2)
- (1)
- (19)
- (3)
- (18)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (29)
- (3)
- (2)
- (1)
- (2)
- (1)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (44)
- (2)
- (27)
- (1)
- (73)
- (6)
- (73)
Filtered Search Results
CERILLIANT™ S(+)-Amphetamine (dextro-Amphetamine) Solution, Sold by MilliporeSigma™ Supelco™
Suitable for use in urine drug testing, clinical toxicology, forensic analysis, and isomer identification by LC-MS/MS or GC/MS.
CERILLIANT™ Remifentanil acid Solution, 100 μg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™
Certified reference material
CERILLIANT™ (±)-Amphetamine-d11 Solution, 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™
Suitable for quantitation of amphetamine levels in urine, serum, or plasma by LC/MS or GC/MS for urine drug testing, clinical toxicology, forensic analysis, or sports testing.
CERILLIANT™ p-Fluorobutyryl fentanyl (PFBF) Solution, 100 μg/mL in Methanol (), Sold by MilliporeSigma™ Supelco™
Certified reference material
CERILLIANT™ Morphine Solution, 1.0 mg/mL in Methanol, Sold by MilliporeSigma™ Supelco™
Certified reference material
CERILLIANT™ Multicomponent Alcohol Mix 1000, 1000 μg/mL each component in H2O, Sold by MilliporeSigma™ Supelco™
A multicomponent calibration kit containing acetone, ethanol, isopropanol, and methanol at a concentration of 1000 μg/mL. This kit is suitable for calibration of blood alcohol testing methods using GC Headspace.
Tibolone Impurity Standard, British Pharmacopoeia (BP) Reference Standard, MilliporeSigma™ Supelco™
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, has been developed and issued under the Authority of the issuing Pharmacopoeia.
Methapyrilene HCl, MilliporeSigma™ Supelco™
Methapyrilene is an H1-receptor antihistamine that is known to cause periportal hepatic necrosis following acute high dose administration to the rat subjects in in vitro studies carried out for the identification of mutagens and/or carcinogens.
Pimobendan, Thermo Scientific™
CAS: 74150-27-9 Molecular Formula: C19H18N4O2 Molecular Weight (g/mol): 334.38 MDL Number: 00761648 InChI Key: GLBJJMFZWDBELO-UHFFFAOYNA-N IUPAC Name: 6-[2-(4-methoxyphenyl)-1H-1,3-benzodiazol-6-yl]-5-methyl-2,3,4,5-tetrahydropyridazin-3-one SMILES: COC1=CC=C(C=C1)C1=NC2=CC=C(C=C2N1)C1=NNC(=O)CC1C
| CAS | 74150-27-9 |
|---|---|
| Molecular Weight (g/mol) | 334.38 |
| MDL Number | 00761648 |
| SMILES | COC1=CC=C(C=C1)C1=NC2=CC=C(C=C2N1)C1=NNC(=O)CC1C |
| IUPAC Name | 6-[2-(4-methoxyphenyl)-1H-1,3-benzodiazol-6-yl]-5-methyl-2,3,4,5-tetrahydropyridazin-3-one |
| InChI Key | GLBJJMFZWDBELO-UHFFFAOYNA-N |
| Molecular Formula | C19H18N4O2 |
Amoxicillin Trihydrate 98.0+%, TCI America™
CAS: 61336-70-7 Molecular Formula: C16H25N3O8S Molecular Weight (g/mol): 419.449 MDL Number: MFCD00072029 InChI Key: MQXQVCLAUDMCEF-FXHJIJKUSA-N PubChem CID: 124080955 IUPAC Name: (2S,5R,6S)-6-[[(2S)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;trihydrate SMILES: CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C.O.O.O
| PubChem CID | 124080955 |
|---|---|
| CAS | 61336-70-7 |
| Molecular Weight (g/mol) | 419.449 |
| MDL Number | MFCD00072029 |
| SMILES | CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C.O.O.O |
| IUPAC Name | (2S,5R,6S)-6-[[(2S)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;trihydrate |
| InChI Key | MQXQVCLAUDMCEF-FXHJIJKUSA-N |
| Molecular Formula | C16H25N3O8S |
CERILLIANT™ (±)-Amphetamine-d5 (deuterium label on side chain) Solution, 100 μg/mL, Sold by MilliporeSigma™ Supelco™
Suitable for quantitation of amphetamine levels in urine, serum, or plasma by LC/MS or GC/MS for urine drug testing, clinical toxicology, forensic analysis, or sports testing.
Cerilliant™ Buprenorphine Glucuronide Solution, 100 μg/mL in methanol, Certified Reference Material, MilliporeSigma™ Supelco™
Buprenorphine glucuronide is a major urinary metabolite of the semi-synthetic opioid, buprenorphine.
CERILLIANT™ Buprenorphine-D4 Solution, 100 μg/mL in methanol, Sold by MilliporeSigma™ Supelco™
An internal standard suitable for buprenorphine testing or isotope dilution methods by GC/MS or LC/MS for clinical toxicology, pain prescription monitoring, urine drug testing, or forensic analysis.
CERILLIANT™ Carisoprodol-D7 Solution, 100 μg/mL in methanol, Sold by MilliporeSigma™ Supelco™
An internal standard for Carisoprodol testing or isotope dilution methods by GC/MS or LC/MS for clinical toxicology, urine drug testing, pain prescription monitoring or forensic analysis.
CERILLIANT™ Ethyl sulfate sodium salt, 10 mg/mL in Methanol:Water (1:1), Sold by MilliporeSigma™ Supelco™
Certified reference material